Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,395 | 12,749 | 19,984 | 17,498 | 23,506 |
| Marketable Securities | N/A | N/A | 214 | 2,526 | 5,205 |
| Receivables | 45,819 | 47,490 | 40,663 | 51,256 | 47,944 |
| Inventories | 35,879 | 29,308 | 26,004 | 25,135 | 29,725 |
| Income taxes - deferred | 3,319 | 3,570 | 3,779 | 2,303 | 3,148 |
| TOTAL | $109,261 | $105,946 | $100,560 | $113,372 | $123,144 |
| Non-Current Assets | |||||
| PPE Net | 142,187 | 145,048 | 149,796 | 157,153 | 162,189 |
| Investments And Advances | 956 | 956 | 956 | 956 | 956 |
| Intangibles | 3,062 | 2,992 | 2,976 | 20,272 | 22,032 |
| Other Non-Current Assets | 11,913 | 8,427 | 8,779 | 4,300 | 2,967 |
| TOTAL | $158,118 | $157,423 | $162,507 | $182,681 | $188,144 |
| Total Assets | $267,379 | $263,369 | $263,067 | $296,053 | $311,288 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 418 | 2,439 | 2,839 | 6,239 | 6,639 |
| Accounts payable and accrued liabilities | 27,979 | 24,997 | 20,424 | 25,948 | 26,917 |
| Accrued Expenses | 871 | 1,523 | 4,167 | 296 | 811 |
| Other current liabilities | 3,400 | 3,741 | 4,082 | 4,765 | 4,765 |
| TOTAL | $39,838 | $40,032 | $37,976 | $44,005 | $48,241 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,587 | 3,002 | 3,003 | 3,004 | 3,005 |
| Deferred Revenues | 7,170 | 7,332 | 6,464 | 6,757 | 9,109 |
| Other Non-Current Liabilities | 10,553 | 10,309 | 10,635 | 7,532 | 7,621 |
| TOTAL | $22,540 | $17,989 | $18,657 | $16,323 | $16,810 |
| Total Liabilities | $62,378 | $58,021 | $56,633 | $60,328 | $65,051 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,806 | 30,769 | 30,772 | 30,640 | 30,659 |
| Common Shares | 362 | 362 | 360 | 361 | 360 |
| Retained earnings | 75,404 | 75,147 | 78,954 | 103,363 | 109,215 |
| Other shareholders' equity | -10,984 | -9,803 | -11,954 | -6,706 | -1,281 |
| TOTAL | $205,001 | $205,348 | $206,434 | $235,725 | $246,237 |
| Total Liabilities And Equity | $267,379 | $263,369 | $263,067 | $296,053 | $311,288 |